Immunomodulatory properties of Alternanthera tenella Colla aqueous extracts in mice.
Plants from the genus Alternanthera are thought to possess antimicrobial and antiviral properties. In Brazilian folk medicine, the aqueous extract of A. tenella Colla is used for its anti-inflammatory activity. The present study investigated the immunomodulatory property of A. tenella extract by evaluating the antibody production in male albino Swiss mice weighing 20-25 g (10 per group). The animals received standard laboratory diet and water ad libitum. The effect of A. tenella extract (5 and 50 mg/kg, ip) was evaluated in mice immunized with sheep red blood cells (SRBC 10%, ip) as T-dependent antigen, or in mice stimulated with mitogens (10 micro g, Escherichia coli lipopolysaccharide, LPS, ip). The same doses (5 and 50 mg/kg, ip) of A. tenella extract were also tested for antitumor activity, using the Ehrlich ascites carcinoma as model. The results showed that 50 mg/kg A. tenella extract ip significantly enhanced IgM (64%) and IgG2a (50%) antibody production in mice treated with LPS mitogen. The same dose had no effect on IgM-specific response, whereas the 5 mg/kg treatment caused a statiscally significant reduction of anti-SRBC IgM-specific antibodies (82%). The aqueous extract of A. tenella (50 mg/kg) increased the life span (from 16 +/- 1 to 25 +/- 1 days) and decreased the number of viable tumor cells (59%) in mice with Ehrlich ascites carcinoma. The present findings are significant for the development of alternative, inexpensive and perhaps even safer strategies for cancer treatment.
Guerra
R N M
RN
Laborat rio de Imunofisiologia, Departamento de Patologia, Universidade Federal do Maranhão, São Luíz, MA Brasil. rguerra@elo.com.br
Pereira
H-A W
HA
Silveira
L M S
LM
Olea
R S G
RS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D027703:Amaranthaceae / Q000737:chemistry*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D051379:Mice; D010936:Plant Extracts / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts